Works matching DE "ERLOTINIB"

Results: 1035

Positive Osimertinib Patch Test in a Bullous Lichenoid Drug Reaction.

Published in:

Contact Dermatitis (01051873), 2025, v. 93, n. 2, p. 165, doi. 10.1111/cod.14810

By:

Marcombes, Clarisse;
Bel Hareth, Kamar;
Mazoyer, Héloïse;
Solinas, Sabina;
Ingen‐Housz‐Oro, Saskia;
Assier, Haudrey

Publication type:

Article

Physicochemical characterization and biological evaluation of amorphous solid dispersions of an anticancerous drug: Erlotinib HCl.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-07692-1

By:

Safna Hussan, K. P.;
Babu, Thekkekara D.;
Thayyil, M. Shahin;
Sreeshma, T. S.;
Archana, A.

Publication type:

Article

Design and Synthesis of Indole-oxazole-benzamide Conjugates; In Vitro Anticancer Evaluation and ADMET Studies.

Published in:

Russian Journal of General Chemistry, 2025, v. 95, n. 6, p. 1331, doi. 10.1134/S107036322560016X

By:

Kandukuri, P.;
Tula, K.;
Dasari, G.;
Bandari, S.;
Juluru, B.

Publication type:

Article

Single-agent erlotinib versus oral etoposide in patients with recurrent or refractory pediatric ependymoma: a randomized open-label study.

Published in:

Journal of Neuro-Oncology, 2016, v. 129, n. 1, p. 131, doi. 10.1007/s11060-016-2155-4

By:

Jakacki, Regina;
Foley, Margaret;
Horan, Julie;
Wang, Jiuzhou;
Kieran, Mark;
Bowers, Daniel;
Bouffet, Eric;
Zacharoulis, Stergios;
Gill, Stan

Publication type:

Article

A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients.

Published in:

Journal of Neuro-Oncology, 2016, v. 126, n. 1, p. 185, doi. 10.1007/s11060-015-1958-z

By:

Raizer, J.;
Giglio, P.;
Hu, J.;
Groves, M.;
Merrell, R.;
Conrad, C.;
Phuphanich, S.;
Puduvalli, V.;
Loghin, M.;
Paleologos, N.;
Yuan, Y.;
Liu, D.;
Rademaker, A.;
Yung, W.;
Vaillant, B.;
Rudnick, J.;
Chamberlain, M.;
Vick, N.;
Grimm, S.;
Tremont-Lukats, I.

Publication type:

Article

Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab.

Published in:

Journal of Neuro-Oncology, 2015, v. 121, n. 2, p. 331, doi. 10.1007/s11060-014-1636-6

By:

Wen, Qiuting;
Jalilian, Laleh;
Lupo, Janine;
Molinaro, Annette;
Chang, Susan;
Clarke, Jennifer;
Prados, Michael;
Nelson, Sarah

Publication type:

Article

Erratum to: Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry.

Published in:

2014

By:

Gallego, Oscar;
Cuatrecasas, M.;
Benavides, M.;
Segura, P.;
Berrocal, A.;
Erill, N.;
Colomer, A.;
Quintana, M.;
Balaña, C.;
Gil, M.;
Gallardo, A.;
Murata, P.;
Barnadas, A.

Publication type:

Erratum

Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry.

Published in:

Journal of Neuro-Oncology, 2014, v. 116, n. 2, p. 413, doi. 10.1007/s11060-013-1316-y

By:

Gallego, Oscar;
Cuatrecasas, M.;
Benavides, M.;
Segura, P.;
Berrocal, A.;
Erill, N.;
Colomer, A.;
Quintana, M.;
Balaña, C.;
Gil, M.;
Gallardo, A.;
Murata, P.;
Barnadas, A.

Publication type:

Article

Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERa and Wnt/β-catenin signaling pathways.

Published in:

Journal of Biochemical & Molecular Toxicology, 2021, v. 35, n. 11, p. 1, doi. 10.1002/jbt.22905

By:

Karaca, Büşra;
Bakır, Elçin;
Yerer, Mükerrem Betül;
Cumaoğlu, Ahmet;
Hamurcu, Zuhal;
Eken, Ayşe

Publication type:

Article

Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment.

Published in:

2016

By:

Baxa, Jan;
Matouskova, Tana;
Krakorova, Gabriela;
Schmidt, Bernhard;
Flohr, Thomas;
Sedlmair, Martin;
Bejcek, Jiri;
Ferda, Jiri

Publication type:

journal article

Relationship between Paronychia and Drug Concentrations of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.

Published in:

Oncology, 2018, v. 95, n. 4, p. 251, doi. 10.1159/000490177

By:

Masago, Katsuhiro;
Irie, Kei;
Fujita, Shiro;
Imamichi, Fumiko;
Okada, Yutaka;
Katakami, Nobuyuki;
Fukushima, Shoji;
Yatabe, Yasushi

Publication type:

Article

Smoking History as a Predictor of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Non-Small Cell Lung Cancer Harboring <bold>EGFR</bold> Mutations.

Published in:

Oncology, 2018, v. 95, n. 2, p. 109, doi. 10.1159/000488594

By:

Nishinarita, Noriko;
Igawa, Satoshi;
Kasajima, Masashi;
Kusuhara, Seiichiro;
Harada, Shinya;
Okuma, Yuriko;
Sugita, Keisuke;
Ozawa, Takahiro;
Fukui, Tomoya;
Mitsufuji, Hisashi;
Yokoba, Masanori;
Katagiri, Masato;
Kubota, Masaru;
Sasaki, Jiichiro;
Naoki, Katsuhiko

Publication type:

Article

A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma.

Published in:

Oncology, 2018, v. 94, n. 6, p. 329, doi. 10.1159/000485384

By:

Thomas, Melanie B.;
Garrett-Mayer, Elizabeth;
Anis, Munazza;
Anderton, Kate;
Bentz, Tricia;
Edwards, Andie;
Brisendine, Alan;
Weiss, Geoffrey;
Siegel, Abby B.;
Bendell, Johanna;
Baron, Ari;
Duddalwar, Vinay;
El-Khoueiry, Anthony

Publication type:

Article

A Prospective Observational Study Evaluating the Correlation of <bold><italic>c-MET</italic></bold> Expression and <bold><italic>EGFR</italic></bold> Gene Mutation with Response to Erlotinib as Second-Line Treatment for Patients with Advanced/Metastatic Non-Small-Cell Lung Cancer

Published in:

Oncology, 2018, v. 94, n. 6, p. 373, doi. 10.1159/000486896

By:

Park, Cheol-Kyu;
Oh, In-Jae;
Choi, Yoo-Duk;
Jang, Tae-Won;
Lee, Jeong-Eun;
Ryu, Jeong-Seon;
Lee, Shin-Yup;
Kim, Young-Chul

Publication type:

Article

Maintenance Treatment by Erlotinib and Toxic Cardiomyopathy: A Case Report.

Published in:

Oncology, 2016, v. 90, n. 3, p. 176, doi. 10.1159/000444186

By:

Pinquié, François;
de Chabot, Gonzagues;
Urban, Thierry;
Hureaux, José

Publication type:

Article

Clinical Predictors of Response to EGFR Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.

Published in:

Oncology, 2014, v. 86, n. 2, p. 86, doi. 10.1159/000357129

By:

Fukihara, Jun;
Watanabe, Naohiro;
Taniguchi, Hiroyuki;
Kondoh, Yasuhiro;
Kimura, Tomoki;
Kataoka, Kensuke;
Matsuda, Toshiaki;
Yokoyama, Toshiki;
Hasegawa, Yoshinori

Publication type:

Article

RECENT ADVANCES OF TARGETED SYNTHESIS, MODIFICATIONS AND BIOACTIVITY OF QUINAZOLINE ALKALOIDS AND THEIR ANALOGUES.

Published in:

Journal of Research in Pharmacy, 2023, v. 27, p. 40

By:

ELMURADOV, B. Zh.;
BERDIEV, A. U.;
JURAEV, B. B.;
KHUDOYKULOVA, R. Z.;
ZULPANOV, F. A.

Publication type:

Article

FGFR Fusions as an Acquired Resistance Mechanism Following Treatment with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) and a Suggested Novel Target in Advanced Non-Small Cell Lung Cancer (aNSCLC).

Published in:

Journal of Clinical Medicine, 2022, v. 11, n. 9, p. 2475, doi. 10.3390/jcm11092475

By:

Raphael, Ari;
Dudnik, Elizabeth;
Hershkovitz, Dov;
Jain, Suyog;
Olsen, Steve;
Soussan-Gutman, Lior;
Ben-Shitrit, Taly;
Dvir, Addie;
Nechushtan, Hovav;
Peled, Nir;
Onn, Amir;
Agbarya, Abed

Publication type:

Article

Enhanced Serum Levels of sFlt1: Impact on Materno–Fetal CMV Transmission.

Published in:

Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1258, doi. 10.3390/jcm9051258

By:

Penka, Lukas;
Kagan, Karl-Oliver;
Hamprecht, Klaus

Publication type:

Article

Physicochemical characterisation and cyclodextrin complexation of erlotinib.

Published in:

Supramolecular Chemistry, 2016, v. 28, n. 7/8, p. 656, doi. 10.1080/10610278.2015.1117083

By:

Tóth, Gergő;
Jánoska, Ádám;
Szabó, Zoltán-István;
Völgyi, Gergely;
Orgován, Gábor;
Szente, Lajos;
Noszál, Béla

Publication type:

Article

Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer: Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World.

Published in:

Oncologist, 2024, v. 29, n. 7, p. 596, doi. 10.1093/oncolo/oyae043

By:

Pasello, Giulia;
Lorenzi, Martina;
Scattolin, Daniela;
Conte, Alessandro Del;
Cecere, Fabiana;
Pavan, Alberto;
Macerelli, Marianna;
Polo, Valentina;
Pilotto, Sara;
Santarpia, Mariacarmela;
Cumerlato, Enrico;
Ros, Valentina Da;
Targato, Giada;
Bortolami, Alberto;
Bonanno, Laura;
Ferro, Alessandra;
Maso, Alessandro Dal;
Frega, Stefano;
Guarneri, Valentina

Publication type:

Article

Liquid Biopsy Testing for the Management of Patient with Non-Small Cell Lung Cancer Carrying a Rare Exon-20 EGFR Insertion.

Published in:

Oncologist, 2022, v. 27, n. 1, p. 7, doi. 10.1093/oncolo/oyab002

By:

Morabito, Alessandro;
Manzo, Anna;
Montanino, Agnese;
Rachiglio, Anna Maria;
Sforza, Vincenzo;
Pasquale, Raffaella;
Costanzo, Raffaele;
Maiello, Monica R;
Sandomenico, Claudia;
Gallo, Marianna;
Palumbo, Giuliano;
Luca, Antonella De;
La Rocca, Antonello;
Martucci, Nicola;
Cecio, Rossella De;
Picone, Carmine;
Lastoria, Secondo;
Normanno, Nicola

Publication type:

Article

Adjuvant Osimertinib: A New Standard of Care.

Published in:

Oncologist, 2021, v. 26, n. 4, p. 263, doi. 10.1002/onco.13634

By:

Jelinek, Michael J.;
Aggarwal, Charu

Publication type:

Article

Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).

Published in:

Oncologist, 2020, v. 25, n. 12, p. e1869, doi. 10.1634/theoncologist.2020-0640

By:

Nosaki, Kaname;
Yamanaka, Takeharu;
Hamada, Akinobu;
Shiraishi, Yoshimasa;
Harada, Taishi;
Himeji, Daisuke;
Kitazaki, Takeshi;
Ebi, Noriyuki;
Shimose, Takayuki;
Seto, Takashi;
Takenoyama, Mitsuhiro;
Sugio, Kenji

Publication type:

Article

A Rare EGFR–SEPT14 Fusion in a Patient with Colorectal Adenocarcinoma Responding to Erlotinib.

Published in:

Oncologist, 2020, v. 25, n. 3, p. 203, doi. 10.1634/theoncologist.2019-0405

By:

Li, Yong;
Zhang, Hai‐Bo;
Chen, Xian;
Yang, Xiaobing;
Ye, Yongsong;
Bekaii‐Saab, Tanios;
Zheng, Yaojie;
Zhang, Yihong

Publication type:

Article

Concurrent EGFR‐TKI and Thoracic Radiotherapy as First‐Line Treatment for Stage IV Non‐Small Cell Lung Cancer Harboring EGFR Active Mutations.

Published in:

Oncologist, 2019, v. 24, n. 8, p. 1031, doi. 10.1634/theoncologist.2019-0285

By:

Zheng, LinPeng;
Wang, Yanmei;
Xu, Zihan;
Yang, Qiao;
Zhu, Guangkuo;
Liao, Xing‐Yun;
Chen, Xiewan;
Zhu, Bo;
Duan, Yuzhong;
Sun, Jianguo

Publication type:

Article

Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild‐Type Non‐Small Cell Lung Cancer.

Published in:

Oncologist, 2019, v. 24, n. 8, p. 1095, doi. 10.1634/theoncologist.2018-0695

By:

Sequist, Lecia V.;
Gray, Jhanelle Elaine;
Harb, Wael A.;
Lopez‐Chavez, Ariel;
Doebele, Robert C.;
Modiano, Manuel R.;
Jackman, David Michael;
Baggstrom, Maria Quintos;
Atmaca, Akin;
Felip, Enriqueta;
Provencio, Mariano;
Cobo, Manuel;
Adiwijaya, Bambang;
Kuesters, Geoffrey;
Kamoun, Walid S.;
Andreas, Karen;
Pipas, J. Marc;
Santillana, Sergio;
Cho, Byoung Chul;
Park, Keunchil

Publication type:

Article

From Diagnostic‐Therapeutic Pathways to Real‐World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR‐Positive Non‐Small Cell Lung Cancer (MOST Study).

Published in:

Oncologist, 2019, v. 24, n. 6, p. e318, doi. 10.1634/theoncologist.2018-0712

By:

Pasello, Giulia;
Vicario, Giovanni;
Zustovich, Fable;
Oniga, Francesco;
Gori, Stefania;
Rosetti, Francesco;
Bonetti, Andrea;
Favaretto, Adolfo;
Toso, Silvia;
Redelotti, Roberta;
Santo, Antonio;
Bernardi, Daniele;
Giovanis, Petros;
Oliani, Cristina;
Calvetti, Lorenzo;
Gatti, Carlo;
Palazzolo, Giovanni;
Baretta, Zora;
Bortolami, Alberto;
Bonanno, Laura

Publication type:

Article

Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non‐Small Cell Lung Cancer.

Published in:

Oncologist, 2019, v. 24, n. 6, p. e251, doi. 10.1634/theoncologist.2018-0089

By:

Buttigliero, Consuelo;
Shepherd, Frances A.;
Barlesi, Fabrice;
Schwartz, Brian;
Orlov, Sergey;
Favaretto, Adolfo G.;
Santoro, Armando;
Hirsh, Vera;
Ramlau, Rodryg;
Blackler, Adele R.;
Roder, Joanna;
Spigel, David;
Novello, Silvia;
Akerley, Wallace;
Scagliotti, Giorgio V.

Publication type:

Article

A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance).

Published in:

Oncologist, 2019, v. 24, n. 5, p. 589, doi. 10.1634/theoncologist.2018-0878

By:

Halfdanarson, Thorvardur R.;
Foster, Nathan R.;
Kim, George P.;
Meyers, Jeffrey P.;
Smyrk, Thomas C.;
McCullough, Ann E.;
Ames, Matthew M.;
Jaffe, Jeffrry P.;
Alberts, Steven R.

Publication type:

Article

Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.

Published in:

Oncologist, 2019, v. 24, n. 5, p. 632, doi. 10.1634/theoncologist.2018-0423

By:

Mitchell, Aaron P.;
Winn, Aaron N.;
Lund, Jennifer L.;
Dusetzina, Stacie B.

Publication type:

Article

Erlotinib as Neoadjuvant Therapy in Stage IIIA (N2) EGFR Mutation‐Positive Non‐Small Cell Lung Cancer: A Prospective, Single‐Arm, Phase II Study.

Published in:

Oncologist, 2019, v. 24, n. 2, p. 157, doi. 10.1634/theoncologist.2018-0120

By:

Xiong, Liwen;
Li, Rong;
Sun, Jiayuan;
Lou, Yuqing;
Zhang, Weiyan;
Bai, Hao;
Wang, Huiming;
Shen, Jie;
Jing, Bo;
Shi, Chunlei;
Zhong, Hua;
Gu, Aiqin;
Jiang, Liyan;
Shi, Jianxing;
Fang, Wentao;
Zhao, Heng;
Zhang, Jie;
Wang, Junyuan;
Ye, Junyi;
Han, Baohui

Publication type:

Article

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study.

Published in:

Oncologist, 2018, v. 23, n. 10, p. 1135, doi. 10.1634/theoncologist.2018-0263

By:

Labots, Mariette;
Van der Mijn, Johannes C.;
Dekker, Henk;
Ruijter, Rita;
Pham, Thang V.;
Van der Vliet, Hans J.;
Van der Hoeven, Jacobus J.M.;
Meijer, Gerrit A.;
Verheul, Henk M.W.

Publication type:

Article

Single Arm, Phase II Study of Cisplatin, Docetaxel, and Erlotinib in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas.

Published in:

Oncologist, 2018, v. 23, n. 5, p. 526, doi. 10.1634/theoncologist.2017-0661

By:

William Jr., William N.;
Tsao, Anne S.;
Feng, Lei;
Ginsberg, Lawrence E.;
Lee, J. Jack;
Kies, Merrill S.;
Glisson, Bonnie S.;
Kim, Edward S.

Publication type:

Article

Epidermal Growth Factor Receptor Inhibition in the Management of Squamous Cell Carcinoma of the Lung.

Published in:

Oncologist, 2016, v. 21, n. 2, p. 205, doi. 10.1634/theoncologist.2015-0209

By:

Goss, Glenwood D.;
Spaans, Johanna N.

Publication type:

Article

Randomized Phase II Trial of Erlotinib Beyond Progression in Advanced Erlotinib-Responsive Non-Small Cell Lung Cancer.

Published in:

Oncologist, 2015, v. 20, n. 11, p. 1298, doi. 10.1634/theoncologist.2015-0136

By:

Halmos, Balazs;
Pennell, Nathan A.;
Fu, Pingfu;
Saad, Shumaila;
Gadgeel, Shirish;
Otterson, Gregory A.;
Mekhail, Tarek;
Snell, Michael;
Kuebler, J. Philip;
Sharma, Neelesh;
Dowlati, Afshin

Publication type:

Article

Continued EGFR Inhibition With Postprogression Chemotherapy: Where Do We Stand?

Published in:

2015

By:

Piotrowska, Zofia;
Sequist, Lecia V.

Publication type:

Opinion

Determination of imatinib mesylate and erlotinib hydrochloride in mice plasma using ultrahigh performance liquid chromatography method.

Published in:

Kuwait Journal of Science, 2018, v. 45, n. 3, p. 57

By:

Demir, Gülen Melike;
Değim, İsmail Tuncer

Publication type:

Article

Computer-Aided Discovery of Potential EGFR Inhibitors by Virtual Screening of Drug Bank, ADMET, Docking, DFT And MD Simulation Studies.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2024, v. 20, p. 86

By:

Roney, Miah;
Dubey, Amit;
Nasir, Muhammad Hassan;
Tufail, Aisha;
Tajuddin, Saiful Nizam;
Mohd Aluwi, Mohd Fadhlizil Fasihi;
Moyeenul Huq, A. K. M.

Publication type:

Article

Erlotinib Loaded Lipidic Nanocarriers for Loco-Regional Therapy in Management of Oral Cancer: In-vitro and In-vivo Evaluation.

Published in:

Malaysian Journal of Medicine & Health Sciences, 2024, v. 20, p. 6

By:

Hariharan, Kartik;
Mehta, Tejal

Publication type:

Article

Novel therapeutic modalities and drug delivery - erlotinib liposomes modified with galactosylated lipid: in vitro and in vivo investigations.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, n. 8, p. 1902, doi. 10.1080/21691401.2017.1396222

By:

Xu, Haoping;
He, Changyu;
Liu, Ying;
Jiang, Jinling;
Ma, Tao

Publication type:

Article

Extended release delivery of erlotinib glutathione nanosponge for targeting lung cancer.

Published in:

Artificial Cells, Nanomedicine & Biotechnology, 2018, v. 46, n. 5, p. 1064, doi. 10.1080/21691401.2017.1360324

By:

Momin, Mufassir Mushtaque;
Zaheer, Zahid;
Zainuddin, Rana;
Sangshetti, Jaiprakash N.

Publication type:

Article

Capsaicin enhances erlotinib-induced cytotoxicity via AKT inactivation and excision repair cross-complementary 1 (ERCC1) down-regulation in human lung cancer cells.

Published in:

Toxicology Research, 2019, v. 8, n. 3, p. 459, doi. 10.1039/c8tx00346g

By:

Chen, Jyh-Cheng;
Ko, Jen-Chung;
Yen, Ting-Chuan;
Chen, Tzu-Ying;
Lin, Yuan-Cheng;
Ma, Peng-Fang;
Lin, Yun-Wei

Publication type:

Article

Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21/ low miR-200c signature in vivo.

Published in:

Scientific Reports, 2013, p. 1, doi. 10.1038/srep02459

By:

Cufí, Sílvia;
Bonavia, Rosa;
Vazquez-Martin, Alejandro;
Oliveras-Ferraros, Cristina;
Corominas-Faja, Bruna;
Cuyàs, Elisabet;
Martin-Castillo, Begoña;
Barrajón-Catalán, Enrique;
Visa, Joana;
Segura-Carretero, Antonio;
Joven, Jorge;
Bosch-Barrera, Joaquim;
Micol, Vicente;
Menendez, Javier A.

Publication type:

Article

Antitumor effects of erlotinib in combination with berberine in A431 cells.

Published in:

BMC Pharmacology & Toxicology, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s40360-023-00661-2

By:

Cuan, Xiangdan;
Yang, Xingying;
Zhu, Weiwei;
Zhao, Yue;
Luo, Rui;
Huang, Yanping;
Wang, Xuanjun;
Sheng, Jun

Publication type:

Article

Pharmacokinetics and Bioequivalence Evaluation of Erlotinib Hydrochloride Tablets: Randomized, Open‐Label, 2‐Period Crossover Study in Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2021, v. 10, n. 2, p. 166, doi. 10.1002/cpdd.811

By:

Wang, Lu;
Ruan, Zourong;
Yang, Dandan;
Hu, Yin;
Liang, Jian;
Chen, Jinliang;
Shao, Rong;
Xu, Yichao;
Guan, Yanlu;
Jiang, Bo

Publication type:

Article

Effect of smoking status on progression-free and overall survival in non-small cell lung cancer patients receiving erlotinib or gefitinib: a meta-analysis.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 6, p. 661, doi. 10.1111/jcpt.12332

By:

Sohn, H. S.;
Kwon, J.‐W.;
Shin, S.;
Kim, H.‐S.;
Kim, H.

Publication type:

Article

A retrospective study of the prescribing and outcomes of tyrosine kinase inhibitors in chronic myeloid leukaemia over a period of more than 10 years.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 4, p. 391, doi. 10.1111/jcpt.12273

By:

Lang, A.‐S.;
Mounier, M.;
Roques, M.;
Chretien, M. L.;
Boulin, M.

Publication type:

Article

Population pharmacokinetics of erlotinib in Japanese patients with advanced non-small cell lung cancer.

Published in:

Journal of Clinical Pharmacy & Therapeutics, 2015, v. 40, n. 2, p. 232, doi. 10.1111/jcpt.12232

By:

Emoto‐Yamamoto, Y.;
Iida, S.;
Kawanishi, T.;
Fukuoka, M.

Publication type:

Article

Genetic Association of Drug Response to Erlotinib in Chinese Advanced Non-small Cell Lung Cancer Patients.

Published in:

Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00360

By:

Wang, Cong;
Chen, Fang;
Liu, Yichen;
Xu, Qingqing;
Guo, Liang;
Zhang, Xiaoqing;
Ruan, Yunfeng;
Shi, Ye;
Shen, Lu;
Li, Mo;
Du, Huihui;
Sun, Xiaofang;
Ma, Jingsong;
He, Lin;
Qin, Shengying

Publication type:

Article